Veterinary Active Pharmaceutical Ingredients Manufacturing Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Veterinary Active Pharmaceutical Ingredients Manufacturing Market From 2025 To 2029?
The market size for manufacturing veterinary active pharmaceutical ingredients has seen significant growth over the past few years. It is projected to increase from $7.46 billion in 2024 to $8.03 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The growth observed in the historic period can be credited to factors such as a rise in pet ownership, strict regulatory standards, amplified emphasis on animal nutrition, investments in research and development, and global economic growth.
The market size for the manufacture of veterinary active pharmaceutical ingredients is predicted to experience robust growth in the forthcoming years. The market is projected to expand to $11.12 billion by 2029 with an 8.5% compound annual growth rate (CAGR). This development during the forecast period is ascribed to improvements in personalized veterinary medicine, market growth and globalization, emphasis on regulatory obedience, increasing concern for animal welfare, advances in drug distribution systems, and surging demand for nutraceuticals. Major forecast period trends encompass progress in manufacturing procedures, the growing trend of API manufacturing outsourcing, a move towards biotechnology-based APIs, the incorporation of automation and digitalization in manufacturing, and the globalization of the veterinary API sector.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
What Are the Core Market Drivers Propelling Growth in the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?
The expansion of the veterinary active pharmaceutical ingredients manufacturing market is likely to be fuelled by the growing prevalence of pet ownership. Pet owners, people who have either purchased or adopted a pet, give their pets the required healthcare, which in turn fuels the demand for veterinary medication. For example, Animal Medicines Australia, a non-governmental organisation based in Australia, reported a notable growth in pet ownership in 2022. Pet owners rose to 28,730.8 in 2022, a significant increase from 39% in 2021, indicating a growth of 24%. The data reveals a prominent uptrend in adopting pets and investing in their care. A rise in pet adoption depicts pets becoming more commonplace in Australian homes. Thus, the expanding pet ownership populace is stimulating the veterinary active pharmaceutical ingredients manufacturing market.
How Is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segmented?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Non-Selective NSAIDs, COX-2 Inhibitors
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=7942&type=smp
Which Regions Are Driving the Next Phase of the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2024. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Veterinary Active Pharmaceutical Ingredients Manufacturing Industry?
In the veterinary active pharmaceutical ingredient manufacturing market, there’s an emerging trend of product innovation. To keep their place in the market, major organizations are zeroing in on novel products. For instance, Zoetis Inc., a US-based company that specializes in drugs for pets and livestock, stated in January 2022 that the US FDA had approved their product Solensia (frunevetmab injection). This product, which controls osteoarthritis (OA) pain in cats, is the only injectable monoclonal antibody treatment for feline OA pain that is permitted in the United States. It operates by pinpointing and counteracting nerve growth factor (NGF), a significant source of pain in OA.
View the full report here:
How Is the Veterinary Active Pharmaceutical Ingredients Manufacturing Market Defined and What Are Its Core Parameters?
Veterinary active pharmaceutical Ingredients (APIs) manufacturing refers to the process of producing chemical compounds that are biologically active and used in the formulation of veterinary medicines. These APIs are essential for treating diseases and managing health in animals, including livestock and pets. The manufacturing process ensures the quality, safety, and efficacy of the medications that improve animal welfare and health outcomes.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7942
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
